Overview of the FDAs Compounded Semaglutide Manufacturing Ban In response to concerns about safety, efficacy, and regulatory oversight, the FDA issued a ruling requiring compounding pharmacies to stop manufacturing compounded semaglutide by May 22, 2025
Does Anthem Medicaid Cover GLP-1s
CJC-1295 Side Effects and Safety: Water Retention, Numbness, Glucose, and What to Watch (2026) CJC-1295 Side Effects: What the Evidence Actually Shows CJC-1295 side effects include water retention, injection-site flushing, transient glucose shifts, and peripheral tingling from carpal-tunnel-like nerve compression
Do not use if the solution appears cloudy, discoloured, or contains visible particles
Generic Semaglutide will only be available as a preloaded injection taken once per week at this time